Investment Thesis
OptimizeRx exhibits weak operational fundamentals with zero revenue growth and negative net income despite a 370% gross margin, indicating severe operational inefficiency or accounting anomalies. The company is burning cash operationally ($467K negative OCF) while carrying debt, with interest coverage below 1x, creating solvency risk despite a strong balance sheet.
Strengths
- Fortress balance sheet with 5.37x current ratio and 0.18x debt-to-equity ratio providing financial stability
- Substantial stockholders' equity of $129.6M relative to total assets of $167.3M indicating low bankruptcy risk
- Adequate cash reserves of $20.2M providing runway for operational adjustments
Risks
- Zero year-over-year revenue growth signals stagnant market position and lack of business expansion
- Negative operating cash flow and free cash flow of -$467K and -$488K indicate the business is not self-sustaining
- Interest coverage ratio of 0.3x is critically low; company cannot service debt from operating earnings, relying on cash reserves
- Net loss of $495K despite positive gross profit reveals severe operational inefficiency or structural cost problems
- Abnormally high 370% gross margin suggests potential data quality issues or unusual business model requiring verification
Key Metrics to Watch
- Revenue growth trajectory and customer acquisition trends in next two quarters
- Path to operating profitability and cash flow breakeven
- Operating expense management and gross margin normalization
Financial Metrics
Revenue
19.8M
Net Income
-495.0K
EPS (Diluted)
$-0.03
Free Cash Flow
-488.0K
Total Assets
167.3M
Cash
20.2M
Profitability Ratios
Gross Margin
370.9%
Operating Margin
2.0%
Net Margin
-2.5%
ROE
-0.4%
ROA
-0.3%
FCF Margin
-2.5%
Balance Sheet & Liquidity
Current Ratio
5.37x
Quick Ratio
5.37x
Debt/Equity
0.18x
Debt/Assets
22.5%
Interest Coverage
0.26x
Long-term Debt
23.6M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-14T07:38:00.060280 |
Data as of: 2026-03-31 |
Powered by Claude AI